valgansiklovir疗效怎么样？

Valganciclovir hydrochloride (valganciclovir hydrochloride) is a prescription antiviral drug. In adults, valganciclovir hydrochloride is used: to treat cytomegalovirus (CMV) retinitis in people with immunodeficiency syndrome (AIDS). When the CMV virus infects the eye, it is called CMV retinitis. If CMV retinitis is not treated, blindness may result. To prevent CMV disease in people who have received a kidney, heart, or kidney-pancreas transplant and are at high risk for CMV disease. Valganciclovir hydrochloride (valganciclovir) is the prodrug of ganciclovir and is rapidly converted into ganciclovir after oral administration. Valganciclovir hydrochloride (valganciclovir, trade name: Valganciclovir, etc.) is an antiviral drug used to treat patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, and to prevent CMV infection in high-risk solid organ transplant patients. Valganciclovir needs to be taken long-term because it only suppresses the infection, not cures it. So, how effective is valganciclovir hydrochloride?

The antiviral effect of valganciclovir hydrochloride tablets (valgansiklovir) has been clinically confirmed by treating AIDS patients with newly diagnosed retinitis (clinical study WV15376). After four weeks of treatment with valganciclovir hydrochloride tablets (valgansiklovir), the detection rate of CMV virus decreased from 46% (32/69) at study entry to 7% (4/55). Oral valganciclovir hydrochloride tablets (valganciclovir hydrochloride) can achieve similar body ganciclovir exposure levels when administered at recommended doses of intravenous ganciclovir, which is effective in the treatment of CMV retinitis.